
EVP and Group CEO-VZ Business · VERIZON COMMUNICATIONS INC · Common Stock
Open-market sale
$51K reported value · 1.1% of prior position
Disclosed 1 business day after execution (deadline: 2)
2 prior trades recorded in this security
1 other actor traded the same direction within 14 days
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Venkatesh VandanaEVP and Chief Legal Officer | Grant or award | A | $1,277 97 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 9 | Schulman Daniel HDirector, CEO | Grant or award | A | $2,661 202 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 9 | Skiadas Anthony TEVP and CFO | Grant or award | A | $1,738 132 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 2 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,738 132 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 9 | Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer | Grant or award | A | $1,738 132 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 9 | Stillwell Mary-LeeSVP and Controller | Grant or award | A | $585 44 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 9 | Russo Joseph J.EVP&Pres-Global Networks&Tech | Grant or award | A | $1,104 84 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 0 | Malady KyleEVP and Group CEO-VZ Business | Open-market sale · 10b5-1 plan | SELL | $49K 1,100 sh | Nov 4, 2026 traded Nov 3, 2026 | |
| 9 | Schelling ChristinaEVP & Chief People Officer | Grant or award | A | — 11.2K sh | Nov 3, 2026 traded Nov 1, 2026 | |
| 0 | Malady KyleEVP and Group CEO-VZ Business | Open-market sale · 10b5-1 plan | SELL | $47K 1,100 sh | Oct 28, 2026 traded Oct 27, 2026 | |
| 25 | Pete SessionsRSpouse | Sale | SELL | $15K – $50K | Oct 27, 2026 traded Oct 2, 2026 | |
| 9 | Venkatesh VandanaEVP and Chief Legal Officer | Grant or award | A | $1,277 99 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 2 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 9 | Russo Joseph J.EVP&Pres-Global Networks&Tech | Grant or award | A | $1,104 86 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 9 | Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer | Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 9 | Stillwell Mary-LeeSVP and Controller | Grant or award | A | $585 45 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 9 | Skiadas Anthony TEVP and CFO | Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 1 | Malady KyleEVP and Group CEO-VZ Business | Open-market sale · 10b5-1 plan | SELL | $49K 1,100 sh | Oct 21, 2026 traded Oct 20, 2026 | |
| 6 | Malady KyleEVP and Group CEO-VZ Business | Open-market sale · 10b5-1 plan | SELL | $47K 1,100 sh | Oct 14, 2026 traded Oct 13, 2026 | |
| 20 | Gilbert Ray Cisneros, Jr.DSelf | Purchase | BUY | $1,001 – $15K | Oct 12, 2026 traded Sep 18, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $51,040
Malady Kyle filed this Form 4 reporting a open-market sale of VZ on Sep 29, 2026. It became public on Sep 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.